Analysis and Identification of Putative Novel Peptides Purified from Iranian Endemic Echis Carinatus Sochureki Snake Venom by MALDI-TOF Mass Spectrometry

References
1. Kumar KP, Basheer M. Snake bite: biochemical
changes in blood after envenomation by viper and cobra.
Journal of Medical & Allied Sciences. 2011;1(1):36.
2. Jenkins TP, Ahmadi S, Bittenbinder MA, Stewart
TK, Akgun DE, Hale M, et al. Terrestrial venomous animals,
the envenomings they cause, and treatment perspectives in the
Middle East and North Africa. PLoS neglected tropical
diseases. 2021;15(12):e0009880.
3. Kazandjian TD, Arrahman A, Still KBM, Somsen
GW, Vonk FJ, Casewell NR, et al. Anticoagulant Activity of
Naja nigricollis Venom Is Mediated by Phospholipase A2
Toxins and Inhibited by Varespladib. Toxins. 2021;13(5).
4. Kini RM. Platelet aggregation and exogenous factors
from animal sources. Current drug targets Cardiovascular &
haematological disorders. 2004;4(4):301-25.
5. Zdenek CN, Youngman NJ, Hay C, Dobson J,
Dunstan N, Allen L, et al. Anticoagulant activity of black
snake (Elapidae: Pseudechis) venoms: Mechanisms, potency,
and antivenom efficacy. Toxicology letters. 2020;330:176-84.
6. Latinović Z, Leonardi A, Koh CY, Kini RM,
Trampuš Bakija A, Pungerčar J, et al. The Procoagulant
Snake Venom Serine Protease Potentially Having a Dual,
Blood Coagulation Factor V and X-Activating Activity.
Nasri Nasrabadi et al / Archives of Razi Institute, Vol. 78, No. 5 (2023) 1503-1527 1525
Toxins. 2020;12(6).
7. Kini RM. Anticoagulant proteins from snake
venoms: structure, function and mechanism. The Biochemical
journal. 2006;397(3):377-87.
8. Alvarez-Flores MP, Faria F, de Andrade SA,
Chudzinski-Tavassi AM. Snake Venom Components
Affecting the Coagulation System. In: Gopalakrishnakone P,
Inagaki H, Mukherjee AK, Rahmy TR, Vogel C-W, editors.
Snake Venoms. Dordrecht: Springer Netherlands; 2015. p. 1-
20.
9. Chudzinski-Tavassi A, Carvalho L, Alvarez Flores
M, Andrade S. Exogenous Procoagulant Factors as
Therapeutic and Biotechnological Tools. Blood Disorders and
Transfusion. 2014;5:209-18.
10. Kong Y, Huo JL, Xu W, Xiong J, Li YM, Wu WT.
A novel anti-platelet aggregation tripeptide from Agkistrodon
acutus venom: isolation and characterization. Toxicon :
official journal of the International Society on Toxinology.
2009;54(2):103-9.
11. Lazarovici P, Marcinkiewicz C, Lelkes PI. From
Snake Venom's Disintegrins and C-Type Lectins to AntiPlatelet Drugs. Toxins. 2019;11(5).
12. Kini RM, Koh CY. Metalloproteases Affecting
Blood Coagulation, Fibrinolysis and Platelet Aggregation
from Snake Venoms: Definition and Nomenclature of
Interaction Sites. Toxins. 2016;8(10).
13. Waheed H, Moin SF, Choudhary MI. Snake Venom:
From Deadly Toxins to Life-saving Therapeutics. Current
medicinal chemistry. 2017;24(17):1874-91.
14. Matsui T, Fujimura Y, Titani K. Snake venom
proteases affecting hemostasis and thrombosis. Biochimica et
biophysica acta. 2000;1477(1-2):146-56.
15. Braud S, Bon C, Wisner A. Snake venom proteins
acting on hemostasis. Biochimie. 2000;82(9-10):851-9.
16. Sajevic T, Leonardi A, Križaj I. Haemostatically
active proteins in snake venoms. Toxicon : official journal of
the International Society on Toxinology. 2011;57(5):627-45.
17. Hamza L, Gargioli C, Castelli S, Rufini S, LarabaDjebari F. Purification and characterization of a
fibrinogenolytic and hemorrhagic metalloproteinase isolated
from Vipera lebetina venom. Biochimie. 2010;92(7):797-805.
18. Farzaneh E, Fouladi N, Shafaee Y,
Mirzamohammadi Z, Naslseraji F, Mehrpour O.
Epidemiological study of snakebites in Ardabil Province
(Iran). Electronic physician. 2017;9(3):3986-90.
19. Monzavi SM, Afshari R, Khoshdel AR, Mahmoudi
M, Salarian AA, Samieimanesh F, et al. Analysis of
effectiveness of Iranian snake antivenom on Viper venom
induced effects including analysis of immunologic biomarkers
in the Echis carinatus sochureki envenomed victims. Toxicon
: official journal of the International Society on Toxinology.
2019;158:38-46.
20. Gomes MS, de Queiroz MR, Mamede CC, Mendes
MM, Hamaguchi A, Homsi-Brandeburgo MI, et al.
Purification and functional characterization of a new
metalloproteinase (BleucMP) from Bothrops leucurus snake
venom. Comparative biochemistry and physiology
Toxicology & pharmacology : CBP. 2011;153(3):290-300.
21. Lu Q, Clemetson JM, Clemetson KJ. Snake venoms
and hemostasis. Journal of thrombosis and haemostasis : JTH.
2005;3(8):1791-9.
22. Kornalik F, Blombäck B. Prothrombin activation
induced by Ecarin - a prothrombin converting enzyme from
Echis carinatus venom. Thrombosis research. 1975;6(1):57-
63.
23. Yamada D, Sekiya F, Morita T. Isolation and
characterization of carinactivase, a novel prothrombin
activator in Echis carinatus venom with a unique catalytic
mechanism. The Journal of biological chemistry.
1996;271(9):5200-7.
24. Choudhury M, Suvilesh KN, Vishwanath BS,
Velmurugan D. EC-PIII, a novel non-hemorrhagic
procoagulant metalloproteinase: Purification and
characterization from Indian Echis carinatus venom.
International journal of biological macromolecules.
2018;106:193-9.
25. Yamada D, Morita T. Purification and
characterization of a Ca2+ -dependent prothrombin activator,
multactivase, from the venom of Echis multisquamatus.
Journal of biochemistry. 1997;122(5):991-7.
26. Patra A, Kalita B, Chanda A, Mukherjee AK.
Proteomics and antivenomics of Echis carinatus carinatus
venom: Correlation with pharmacological properties and
pathophysiology of envenomation. Scientific reports.
1526 Nasri Nasrabadi et al / Archives of Razi Institute, Vol. 78, No. 5 (2023) 1503-1527
2017;7(1):17119.
27. Babaie M, Zolfagharian H, Salmanizadeh H,
Mirakabadi AZ, Alizadeh H. Isolation and partial purification
of anticoagulant fractions from the venom of the Iranian snake
Echis carinatus. Acta biochimica Polonica. 2013;60(1):17-20.
28. Mehdizadeh Kashani T, Vatanpour H, Zolfagharian
H, Hooshdar Tehrani H, Heydari MH, Kobarfard F. Partial
Fractionation of Venoms from Two Iranian Vipers, Echis
carinatus and Cerastes persicus Fieldi and Evaluation of Their
Antiplatelet Activity. Iranian journal of pharmaceutical
research : IJPR. 2012;11(4):1183-9.
29. Babaie M, Salmanizadeh H, Zolfagharian H. Blood
coagulation induced by Iranian saw-scaled viper (echis
carinatus) venom: identification, purification and
characterization of a prothrombin activator. Iranian journal of
basic medical sciences. 2013;16(11):1145-50.
30. Gan ZR, Gould RJ, Jacobs JW, Friedman PA,
Polokoff MA. Echistatin. A potent platelet aggregation
inhibitor from the venom of the viper, Echis carinatus. The
Journal of biological chemistry. 1988;263(36):19827-32.
31. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ.
Protein measurement with the Folin phenol reagent. The
Journal of biological chemistry. 1951;193(1):265-75.
32. Nasrabadi NN, Dounighi NM, Ahmadinejad M,
Rabiei H, Tabarzad M, Najafi M, et al. Isolation of the
Anticoagulant and Procoagulant Fractions of the Venom of
Iranian Endemic Echis carinatus. Iranian Journal of
Pharmaceutical Research. 2022;21(1).
33. Laemmli UK. Cleavage of structural proteins during
the assembly of the head of bacteriophage T4. Nature.
1970;227(5259):680-5.
34. Morita T, Iwanaga S. Purification and properties of
prothrombin activator from the venom of Echis carinatus.
Journal of biochemistry. 1978;83(2):559-70.
35. Alvarado J, Gutiérrez JM. Anticoagulant effect of
myotoxic phospholipase A2 isolated from the venom of the
snake Bothrops asper (Viperidae). Revista de biologia
tropical. 1988;36(2b):563-5.
36. Cazenave JP, Ohlmann P, Cassel D, Eckly A,
Hechler B, Gachet C. Preparation of washed platelet
suspensions from human and rodent blood. Methods in
molecular biology (Clifton, NJ). 2004;272:13-28.
37. Hechler B, Dupuis A, Mangin PH, Gachet C.
Platelet preparation for function testing in the laboratory and
clinic: Historical and practical aspects. Research and practice
in thrombosis and haemostasis. 2019;3(4):615-25.
38. Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann
M. In-gel digestion for mass spectrometric characterization of
proteins and proteomes. Nature protocols. 2006;1(6):2856-60.
39. Fahmi L, Makran B, Boussadda L, Lkhider M,
Ghalim N. Haemostasis disorders caused by envenomation by
Cerastes cerastes and Macrovipera mauritanica vipers.
Toxicon : official journal of the International Society on
Toxinology. 2016;116:43-8.
40. Markland FS, Jr., Swenson S. Snake venom
metalloproteinases. Toxicon : official journal of the
International Society on Toxinology. 2013;62:3-18.
41. Gâz Florea ŞA, Gâz Florea A, Kelemen H, Muntean
D-L. Snake Venom Metalloproteinases. Acta Marisiensis -
Seria Medica. 2016;62(1):106-11.
42. Kini RM, Rao VS, Joseph JS. Procoagulant proteins
from snake venoms. Haemostasis. 2001;31(3-6):218-24.
43. Takeya H, Nishida S, Miyata T, Kawada S, Saisaka
Y, Morita T, et al. Coagulation factor X activating enzyme
from Russell's viper venom (RVV-X). A novel
metalloproteinase with disintegrin (platelet aggregation
inhibitor)-like and C-type lectin-like domains. The Journal of
biological chemistry. 1992;267(20):14109-17.
44. Silva MB, Schattner M, Ramos CR, Junqueira-deAzevedo IL, Guarnieri MC, Lazzari MA, et al. A prothrombin
activator from Bothrops erythromelas (jararaca-da-seca)
snake venom: characterization and molecular cloning. The
Biochemical journal. 2003;369(Pt 1):129-39.
45. Kwon JY, Chang AK, Park JE, Shin SY, Yoon SM,
Lee JS. Vibrio extracellular protease with prothrombin
activation and fibrinolytic activities. International journal of
molecular medicine. 2007;19(1):157-63.
46. Nikai T, Taniguchi K, Komori Y, Masuda K, Fox
JW, Sugihara H. Primary structure and functional
characterization of bilitoxin-1, a novel dimeric P-II snake
venom metalloproteinase from Agkistrodon bilineatus venom.
Archives of biochemistry and biophysics. 2000;378(1):6-15.
47. Slagboom J, Kool J, Harrison RA, Casewell NR.
Haemotoxic snake venoms: their functional activity, impact
Nasri Nasrabadi et al / Archives of Razi Institute, Vol. 78, No. 5 (2023) 1503-1527 1527
on snakebite victims and pharmaceutical promise. British
journal of haematology. 2017;177(6):947-59.
48. Teng CM, Ma YH, Ouyang CH. Action mechanism
of the platelet aggregation inducer and inhibitor from Echis
carinatus snake venom. Biochimica et biophysica acta.
1985;841(1):8-14.
49. Ouyang CH, Ma YH, Jih HC, Teng CM.
Characterization of the platelet aggregation inducer and
inhibitor from Echis carinatus snake venom. Biochimica et
biophysica acta. 1985;841(1):1-7.
50. Howes JM, Kamiguti AS, Theakston RD, Wilkinson
MC, Laing GD. Effects of three novel metalloproteinases
from the venom of the West African saw-scaled viper, Echis
ocellatus on blood coagulation and platelets. Biochimica et
biophysica acta. 2005;1724(1-2):194-202.
51. Matsui T, Sakurai Y, Fujimura Y, Hayashi I, Oh-Ishi
S, Suzuki M, et al. Purification and amino acid sequence of
halystase from snake venom of Agkistrodon halys blomhoffii,
a serine protease that cleaves specifically fibrinogen and
kininogen. European journal of biochemistry.
1998;252(3):569-75.
52. Modesto JC, Junqueira-de-Azevedo IL, NevesFerreira AG, Fritzen M, Oliva ML, Ho PL, et al. Insularinase
A, a prothrombin activator from Bothrops insularis venom, is
a metalloprotease derived from a gene encoding protease and
disintegrin domains. Biological chemistry. 2005;386(6):589-
600.
53. Hasson SS, Theakston RD, Harrison RA. Cloning of
a prothrombin activator-like metalloproteinase from the West
African saw-scaled viper, Echis ocellatus. Toxicon : official
journal of the International Society on Toxinology.
2003;42(6):629-34.
54. Loría GD, Rucavado A, Kamiguti AS, Theakston
RD, Fox JW, Alape A, et al. Characterization of 'basparin A,'
a prothrombin-activating metalloproteinase, from the venom
of the snake Bothrops asper that inhibits platelet aggregation
and induces defibrination and thrombosis. Archives of
biochemistry and biophysics. 2003;418(1):13-24.
55. Williams WJ, Esnouf MP. The fractionation of
Russell's-viper (Vipera russellii) venom with special reference
to the coagulant protein. The Biochemical journal.
1962;84(1):52-62.
56. Saikia D, Mukherjee AK. Anticoagulant and
Membrane Damaging Properties of Snake Venom
Phospholipase A2 Enzymes. In: Inagaki H, Vogel C-W,
Mukherjee AK, Rahmy TR, Gopalakrishnakone P, editors.
Snake Venoms. Dordrecht: Springer Netherlands; 2017. p.
87-104.
57. Fatah C, Samah S, Fatima LD. Antiplatelet and
anticoagulant activities of two phospholipase A2s purified
from Cerastes cerastes venom: Structure-function
relationship. Journal of biochemical and molecular
toxicology. 2018;32(12):e22219.
58. Dutta S, Gogoi D, Mukherjee AK. Anticoagulant
mechanism and platelet deaggregation property of a noncytotoxic, acidic phospholipase A2 purified from Indian cobra
(Naja naja) venom: inhibition of anticoagulant activity by low
molecular weight heparin. Biochimie. 2015;110:93-106.
59. Sharma M, Iyer JK, Shih N, Majumder M,
Mattaparthi VS, Mukhopadhyay R, et al. Daboxin P, a Major
Phospholipase A2 Enzyme from the Indian Daboia russelii
russelii Venom Targets Factor X and Factor Xa for Its
Anticoagulant Activity. PloS one. 2016;11(4):e0153770.
60. Amrollahi Byoki E, Zare Mirakabadi A. Partial
purification and characterization of anticoagulant factor from
the snake (echis carinatus) venom. Iranian journal of basic
medical sciences. 2013;16(11):1139-44.
61. Damotharan P, Veeruraj A, Arumugam M,
Balasubramanian T. Biological and Biochemical Potential of
Sea Snake Venom and Characterization of Phospholipase A2
and Anticoagulation Activity. Indian journal of clinical
biochemistry : IJCB. 2016;31(1):57-67.
62. Kemparaju K, Krishnakanth TP, Veerabasappa
Gowda T. Purification and characterization of a platelet
aggregation inhibitor acidic phospholipase A2 from Indian
saw-scaled viper (Echis carinatus) venom. Toxicon : official
journal of the International Society on Toxinology.
1999;37(12):1659-71.